INVESTMENT THEME
Weight-Loss Drugs (GLP-1) stocks
Ahead of earnings, investors weigh both obesity-drug leaders; manufacturing capacity and payer coverage are key, with funds favoring clearer growth.
Constituents today, average +0.04% · Updated 2026-10-28 22:24 UTC+8
Constituents
| Stock | Price (USD) | Today |
|---|---|---|
| LLY Eli Lilly | 1,290.19 | +0.65% |
| NVO Novo Nordisk | 38.43 | -0.62% |
| VKTX Viking | 24.66 | -0.92% |
| AMGN Amgen | 452.66 | +1.05% |
US-listed shares and ADRs. Tickers link to key levels where we cover the stock.
Latest related news
Novo Nordisk Vs. Eli Lilly Q3 Preview: I'd (Now) Buy Both, But Lilly Is My Top Pick — SeekingAlpha
Other themes
AI & Robotics +0.48%Solar & Storage -6.43%BoJ Normalization -0.41%Caffeinated Drinks -0.11%Luxury Groups -0.25%P&C Insurance +0.16%Rare Earths & Critical Minerals -2.23%Quantum Computing -2.08%Large Language Models -0.39%Autonomous Driving -0.18%AI Medical Imaging +4.70%Cardiovascular Innovators +0.29%Gene Editing (CRISPR) +4.02%Streaming Platforms -5.42%Pet Economy +0.20%Small Modular Reactors (SMR) -1.65%Grid & Storage Upgrades -0.27%
Follow this theme in the app
Theme prices, news and constituent charts are in the app, along with one-sentence screening across 8 markets.
Theme constituents are compiled by our research team. For information only; not investment advice or a recommendation.